Comments
Loading...
Passage Bio (PASG) Forecast
NewsEarningsPassage Bio (PASG) OptionsGuidanceDividendsAnalyst RatingsInsider TradesShort InterestPassage Bio (NASDAQ:PASG) Stock Quotes, Forecast and News Summary
Passage Bio Stock (NASDAQ: PASG) stock price, news, charts, stock research, profile.
Compare
EPS worse than industry
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
Earnings Per Share
EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.
EPS worse than industry
FAQ
How do I buy Passage Bio (PASG) stock?
You can purchase shares of Passage Bio (NASDAQ:PASG) through any online brokerage.
Who are Passage Bio (PASG) competitors?
Other companies in Passage Bio’s space includes: Serina Therapeutics (AMEX:SER), Estrella Immunopharma (NASDAQ:ESLA), Gain Therapeutics (NASDAQ:GANX), OncoCyte (NASDAQ:OCX) and Barinthus Biotherapeutics (NASDAQ:BRNS).
What is the forecast, or price target, for Passage Bio (PASG) stock?
Passage Bio has a consensus price target of $7.25.
What is the current price for Passage Bio (PASG)?
The stock price for Passage Bio (NASDAQ: PASG) is $0.63 last updated December 18, 2024 at 1:37 PM EST.
Does Passage Bio (PASG) pay a dividend?
There are no upcoming dividends for Passage Bio.
When is Passage Bio (NASDAQ:PASG) reporting earnings?
Passage Bio’s Q4 earnings are confirmed for Monday, March 3, 2025.
Is Passage Bio (PASG) going to split?
There is no upcoming split for Passage Bio.
What sector and industry does Passage Bio (PASG) operate in?
Passage Bio is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.